Pyranoindoles for treating glaucoma

Details for Australian Patent Application No. 2001216034 (hide)

Owner Alcon, Inc.

Inventors Chen, Hwang-Hsing; May, Jesse A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001216034

PCT Pub. Number WO01/70745

Priority 60/190,285 17.03.00 US

Filing date 14 November 2000

Wipo publication date 3 October 2001

Acceptance publication date 7 October 2004

International Classifications

C07D 491/04 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 209/00 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 311/00 Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

A61K 031/535 - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Event Publications

7 October 2004 Application Accepted

  Published as AU-B-2001216034

3 February 2005 Standard Patent Sealed

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001216035

2001216032